Aesthetic pharmaceutical company Allergan has announced a company milestone as it has manufactured 100 million syringes of its Juvéderm dermal filler.
The brand began producing Juvéderm in 2004, and reached the 100 million milestone in April 2022 as the filler is now distributed worldwide.
Djamshid Ghavami, general manager at Allergan Aesthetics UK&I, said, “We are hugely proud of this achievement of reaching such a significant milestone. For us it represents so many patient experiences, and empowering confidence. We couldn’t have reached this milestone without the collaboration between the Allergan Aesthetics team and the expert skill of our practitioners. We recognise that despite reaching a significant milestone, our journey continues and there is still so much more to come as we go beyond 100 million syringes!”